Interferon-gamma gene polymorphism in Iranian patients with multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Genetics

Background:

• Interferon-gamma (IFN-γ) is a key immune regulator and inflammatory cytokine implicated in multiple sclerosis (MS) pathogenesis.
• A specific single nucleotide polymorphism at position +874 in the first intron of the IFN-γ gene influences IFN-γ production levels.

Purpose of the Study:

• To investigate the association between the IFN-γ +874 polymorphism and susceptibility to multiple sclerosis.
• To determine if this polymorphism correlates with the severity of MS.

Main Methods:

• Genomic DNA samples were collected from clinically definite MS patients and their unaffected first-degree relatives.
• Sequence-specific primers and polymerase chain reaction-sequence specific primer (PCR-SSP) techniques were employed to screen for the polymorphism.

Main Results:

• MS patients exhibited a lower frequency of TT genotypes (21.2%) and a higher frequency of AA genotypes (21.2%) compared to controls (30.3% TT, 12.1% AA).
• Despite observed differences in genotype frequencies, statistical analysis revealed no significant differences in IFN-γ genotype distribution between MS patients and controls.
• No statistically significant association was found between the IFN-γ +874 polymorphism and MS susceptibility or disease severity.

Conclusions:

• The interferon-gamma +874 polymorphism is not associated with an increased risk of developing multiple sclerosis.
• This genetic variation does not appear to influence the severity of multiple sclerosis.
• Further research may be needed to explore other genetic factors contributing to MS pathogenesis.